PubMed Health⌕ Search

SEARCH · PubMed Health

Results for “IMMUNE SERUMS”

Explore indexed PubMed citations for clinical trials, systematic reviews and public health research. Read source abstracts and follow each citation to its original PubMed record.

Quote a phrase for an exact phrase match. Source license links do not imply unrestricted reuse.

At least 145 records · Page 8Linked to original sources

A new preparation of modified immune serum globulin (human) suitable for intravenous administration. II. Functional characterization.

The commercial immune serum globulin (ISG) product is suitable for use in passive immunization only by intramuscular administration; intravenous use results in vasomotor side reactions. We report the functional characterization of a chemically modified ISG (MISG) that is essentially free of nonspecific complement-binding activity and contains no new antigenic determinants. The half-life values for MISG given intravenously to rabbits, guinea pigs, and humans are shown not to be different from that of ISG. The MISG we describe is shown to fulfill the in vitro and in vivo criteria of stability, safety, function, and half-life, making it suitable for human intravenous administration.

Animals↗

Humoral immunity in experimental syphilis. II. The relationship of neutralizing factors in immune serum to acquired resistance.

Evidence for a humoral mechanism in immunity to experimental syphilis was provided by the demonstration of immune rabbit serum factor(s) capable of inactivating virulent Treponema pallidum, Nichols strain, in an in vitro-in vivo neutralization test. After intratesticular infection, rabbits were bled periodically and their resistance to reinfection was determined by challenge with T. pallidum. The results of challenge showed that resistance to reinfection begins to develop by 11 days after infection, becomes complete by 3 months, and persists for at least 2 years. In the neutralization test, a mixture of treponemal suspension and serum from the infected animals was incubated anaerobically at 34 degrees C and the virulence of the treponemes was determined by intradermal inoculation into normal rabbits. Complete inactivation of treponemes by immune serum required heat-stable and heat-labile (56 degrees C, 30 min) serum components and 16 hr of incubation, and was accelerated by pre-incubation of the treponemes for 4 hr with nonimmune serum but not by 100 mug/ml of added lysozyme. Serum-neutralizing activity, first demonstrable 1 month postinfection, was quantitated by a neutralizing endpoint (NEP). A relatively close quantitative correlation was shown between the development of resistance to symptomatic reinfection and the appearance and persistence of both TPI antibody and neutralizing serum factor(s). The nature of the serum factor(s), the mechanism of treponemal inactivation, and the application of the test in assessing the immune status are discussed.

Animals↗

Effect of immune serum or polymyxin B on Escherichia coli-induced inflammation and vascular injury.

Bacterial invasion of the tissues often stimulates a vigorous inflammatory reaction, which may limit the spread of microorganisms but may also be accompanied by serious vascular injury and tissue damage. We previously studied the inflammatory reaction induced by the injection of killed Escherichia coli into rabbit skin, a model suitable for the quantitation of various parameters of inflammation. Here we report the effect of immune serum treatment of the E. coli on their capacity to induce inflammation and vascular injury. Injection of killed E. coli treated with immune serum elicited a reaction which had a smaller increase in vascular permeability (protein exudation), measured with (125)I-labeled albumin, less increase in blood flow, measured with (86)RbCl, less leukocyte infiltration, measured with (51)Cr-labeled leukocytes, and a lesser degree of hemorrhage, measured with (59)Fe-labeled erythrocytes, than E. coli treated with nonimmune serum. Crossover experiments with four different E. coli serotypes and four different antisera indicated that antibody to specific O antigens or a related antigen, but not to K or H antigen, was important for modifying the inflammatory response. Treatment of four different E. coli serotypes with antiserum to "core" glycolipid, produced by immunization with the E. coli J5 mutant, inhibited the inflammatory response to all four E. coli serotypes. Finally, treatment of killed E. coli with polymyxin B also inhibited their inflammation-inducing potential. These results suggest that it may be possible to diminish the magnitude of local vascular and tissue injury associated with E. coli infections by the use of antisera or polymyxin B, which bind to endotoxin on the E. coli.

Animals↗

Role of immune serum globulin in post transfusion virus B infection.

Fifty four blood recipients were administered prophylactic immune serum globulin (31) or hepatitis B immune globulin (23) and followed up for six months. None of the patients developed either acute hepatitis B or HBsAg carrier state. However, 7 (14%) had anicteric self limiting non-B post-transfusion hepatitis. Twenty (40%) of the blood recipients developed anti-HBs during the follow up period suggesting either HBV exposure by subdetectable levels of HBsAg present either in blood or immunoglobulin preparation or due to passive transfer by administration of immunoglobulins.

Adult↗

Activation of latent herpesvirus hominis in explants of rabbit trigeminal ganglia: the influence of immune serum.

More than fifty albino rabbits were inoculated into the right scarified cornea with 10(7) PFU of the Kupka strain of human herpes virus type 1 (HHV-1). At intervals ranging from 4--280 days post infection (p.i.), both gasserian ganglia, both trigeminal nerve trunks and pieces from brain stem and from both corneas were explanted. Activation of the latent HHV-1 was found mainly in the homolateral ganglion tissue, but also in explants originating from the opposite ganglia. Within 24--72 hours, prior to the release of virus into the medium, one infectious unit of HHV was recovered from 10(4)--10(5) cells of the ganglion explant. In addition, a few neurons and satellite cells revealed the presence of virus-specific antigens when the explants were examined by immunofluorescence in serial sections. If the gangia were explanted in the presence of immune serum, the virus recovery rate was at least twice lower as compared to the virus activation in explants kept in the absence of immune serum.

Animals↗

Antigen-specific augmentation factor involved in murine delayed-type footpad reaction. II. Augmentation of delayed-type footpad reaction and acquired resistance to Listeria monocytogenes by transfer of Listeria-immune serum.

We previously found an antigen-specific factor capable of augmenting delayed-type hypersensitivity (DTH) in the culture supernatant of the mixture of immune spleen cells and erythrocyte antigen, or in the serum of mice immunized with heterologous erythrocytes and exhibiting delayed-type footpad reaction. To elucidate whether this kind of factor (DTH-augmentation factor; DAF) participates in the establishment of DTH to various kinds of antigen besides erythrocyte antigen, we chose a bacterial antigen, Listeria monocytogenes, which is a facultative intracellular bacterium. In the present study, we demonstrated that the immune serum from mice immunized with viable Listeria augmented the delayed-type footpad reaction to Listeria. Furthermore, acquired resistance against Listeria was also augmented by the transfer of such immune serum. Such augmentation of acquired resistance was observed in sites infected locally and in the spleen of mice infected systemically. This effect was also seen in sera from mice immunized with heat-killed Listeria emulsified with complete Freund's adjuvant.

Animals↗

A quantitative enzyme-linked immunoassay for serum immune complexes.

A sensitive, quantitative, non-complement dependent enzyme-linked immunoassay (ELIA) for human serum immune complexes has been developed utilizing the L1210 murine leukemia cell and peroxidase-conjugated anti-IgG. At end-point O-dianisidine dihydrochloride method was developed which detects as little as 16.45 x 10(-5) purpurogallin units of horse radish peroxidase. The L1210 ELIA requires only five microliters of serum and reproducibly quantitates as little as 55 nanograms of an artificial immune complex standard (heat aggregated IgG). The validity of using aggregated IgG as a standard was demonstrated by the fact that it produced a dose dependent inhibition of binding of a known immune complex (peroxidase-anti-peroxidase) to the L1210 cells whereas monomeric IgG showed no inhibition. Results of the L1210 ELIA are similar to those of the L1210 radioimmune assay (RIA) which we have previously reported. There was no significant difference in mean immune complex levels between the ELIA and the RIA when serums from normal healthy blood donors were tested. A strong correlation (rs equals +0.787) of immune complex levels as determined by the ELIA and the RIA was found in 17 serum samples from patients with disease associated with elevated levels of circulating immune complexes.

Animals↗

INTERACTION OF VISCID MATERIAL OF STAPHYLOCOCCUS AUREUS WITH SPECIFIC IMMUNE SERUM.

Mudd, Stuart (U.S. Veterans Administration Hospital, Philadelphia, Pa.), and Samuel J. DeCourcy, Jr. Interaction of viscid material of Staphylococcus aureus with specific immune serum. J. Bacteriol. 89:874-879. 1965.-Re-examination of the phenomenon of Price and Kneeland and of Wiley revealed the following. (i) The prototype "wound strain" of Wiley, and viscid-colony strains obtained by aging and selection of laboratory or field strains, differed in growth characteristics in liquid and solid media from the Smith encapsulated strain and from ordinary, unselected laboratory and field strains of coagulase-positive staphylococci. (ii) The wound strain and ordinary unselected strains, unlike the Smith encapsulated strain, did not exhibit capsules when examined in thin films of Pelikan Waterproof Drawing Ink. (iii) The phenomenon of Price and Kneeland and of Wiley is exhibited when the wound strain and other viscid-colony strains interact with anti-Wiley immune sera or various human sera. In our experience, this phenomenon was not exhibited by the Smith or by ordinary, unselected strains. (iv) The staphylococcal polysaccharide antigen previously characterized as the capsular substance of a Smith-like strain was completely different chemically and serologically from extracellular material prepared from the Wiley wound strain. We conclude that the viscid-colony strains are not, in fact, encapsulated, and that the phenomenon in question is a precipitation of extracellular material about the periphery of the cells.

Culture Media↗

Kinetics of Cryptosporidium parvum sporozoite neutralization by monoclonal antibodies, immune bovine serum, and immune bovine colostrum.

Monoclonal antibodies, immune bovine serum, and immune bovine colostral whey neutralized infectivity of Cryptosporidium parvum sporozoites for mice in a time-dependent manner. Immune colostral whey neutralized sporozoites more rapidly and completely than immune serum, monoclonal antibody (MAb) 18.44, or a combination of MAb 18.44 and MAb 17.41. Mice were partially protected against oral challenge with C. parvum oocytes when treated with immune colostral whey, MAb 17.41, or a combination of MAb 17.41 and MAb 18.44.

Animals↗

Identification of in vivo pellicle constituents by analysis of serum immune responses.

Human acquired enamel pellicle is composed of molecules that selectively adsorb from saliva onto tooth surfaces and provides a protective interface between the tooth enamel and the oral environment. To identify the micro-amounts of components present in pellicle, we immunized mice with in vivo-formed human acquired enamel pellicle and analyzed the serum immune responses. Selective reactivities of the serum (OD > 1.0 above background) against albumin, amylase, carbonic anhydrase II, sIgA, IgG, IgM, lactoferrin, lysozyme, proline-rich proteins, statherin, histatin 1, and mucous glycoprotein 1 were observed. We further confirmed the presence of proline-rich proteins, lactoferrin, lysozyme, and carbonic anhydrase II by probing in vivo pellicle with specific polyclonal anti-sera. The polyclonal antibody approach provided a powerful method for the identification of various pellicle proteins, including some which show mineral homeostasis or antimicrobial activity.

Adjuvants, Immunologic↗

Immunization of mice against Trypanosoma cruzi: the effect of chemical treatment or immune serum on an epimastigote vaccine.

Groups of long Evans and CD-1 mice were immunized with vaccines prepared from epimastigotes of Trypanosoma cruzi, strains Y and Tulahuen, modified by various chemical means, or by the addition of immune sera. Freeze-thawed epimastigotes were used as a control antigen. Freeze-thawed epimastigotes, with and without saponin as adjuvant, gave significant protection against challenge with homologous trypomastigotes. Similar levels or protection were obtained in mice vaccinated with living epimastigotes. Treatment of epimastigotes by various chemical means, including sodium perchlorate failed to increase their immunogenicity, but did not reduce it. The addition of immune serum to the antigen may have slightly increased its immunogenicity.

Adjuvants, Immunologic↗

Quantitative alterations of immune serum globulin concentrations in pigs transplanted with a renal allograft.

The variation of immune serum globulin concentrations in 14 pigs was determined after unilateral allogenic renal transplantation. Measures by which it is possible to exert certain immunological influences were not taken. Subsequent to transplantation there was observed a significant decrease in both IgM and IgG which was not correlated with the behaviour of plasma proteins and albumin. Because of the relatively small loss of IgG in the urine of animals on which transplantations were performed, this cannot be considered to be the cause of the decrease in immunoglobulin. It was already on the 3rd day after transplantation that an increase in IgM was observed which after reaching a peak of about + 30% was again followed by a distinct decrease of which the minimum was noted between the 6th and 15th days after transplantation. 10 animals died within the first phase, and in 4 of them death occurred on account of rejection for which histological evidence could be obtained. Although 3 of the 4 animals surviving for a longer period of time were also observed to suffer from distinct rejective crises between the 8th and 15th day after transplantation, they were able to overcome those crises without any therapeutical intervention. After some time, however, they were experiencing another IgM peak (this time greater than + 80%) which was followed, after 3 to 11 days, but the final crisis of rejection and death of the animal. In a few cases, glomerular IgM deposits were found in transplanted kidneys.

Animals↗

Use of immune serum globulin (human) to reduce mortality in newly imported rhesus monkeys (Macaca mulatta).

Immune serum globulin (human) (ISGH) was administered intramuscularly to approximately 5,600 rhesus monkeys weighing between 1.5 and 3.6 kg. The animals were housed at three separate facilities under differing quarantine conditions. ISGH recipients were grossly healthier, suffered less morbidity and fewer developed antibodies against measles (rubeola) virus. Mortality among ISGH-treated animals was only 20-57% of that in the control animals. No adverse effects were seen from the injection of ISGH into rhesus monkeys, and residual antibodies from the injected material could not be detected 18 and 47 days postinoculation.

Animals↗

Single and booster dose responses to an inactivated hepatitis A virus vaccine: comparison with immune serum globulin prophylaxis.

Pre- and postexposure prophylaxis against hepatitis A virus (HAV) infection with immune serum globulin (Ig) is only effective for 4-6 months. We compared the safety, tolerability and immunogenicity of a single i.m. injection of Ig with a single and booster dose of an inactivated hepatitis A virus vaccine (iHAV) in adults. Healthy volunteers (18-50 years) received a single Ig i.m. injection (n = 30), or iHAV i.m. (n = 15) at 0 and 24 weeks, or placebo (n = 4) at the same intervals. Anti-HAV seroconversion was measured by radioimmunoassay (RIA) and neutralizing antibodies by an antigen reduction assay. After Ig injection (0.06 ml/kg), anti-HAV seroconversion occurred in 100% of recipients at week 1, declining to 10% at week 12 and 0% by week 20. In contrast, after a single 25 ng dose, RIA seropositivity in iHAV vaccinees was 80% by week 2, reaching 100% by week 5 and persisted up to week 24, at which time anti-HAV geometric mean titres (GMT) were two fold higher than those seen at week 1 after Ig. Postbooster anti-HAV titres in iHAV recipients rose within 4 weeks to 73-fold greater than the peak GMT seen one week after Ig, and 400-fold higher than GMT at 12 weeks after Ig. Neutralizing antibody titres after iHAV followed a similar pattern, as observed for anti-HAV. iHAV was well tolerated; placebo and vaccine tolerability were indistinguishable, with no serious adverse experiences observed. In conclusion, active vaccination with a single iHAV dose may eventually replace Ig for pre-exposure prophylaxis.(ABSTRACT TRUNCATED AT 250 WORDS)

Adolescent↗

[Tetanus prevention with vaccine and with vaccine plus heterologous immune serum: serum antibody levels in the rabbit].

Haemagglutinating antibodies have been assessed in rabbits undergoing active- passive immunization against tetanus. The animals received 6 injections of horse immune serum, 400 UI/kg, and A1PO4 adsorbed toxoid, 0.35 Lf/kg, every 30th day. One the 5th day, after the first injection, E.A. antibodies appeared, at low levels, as a result of a passive immunization. Thereafter the tests became negative, up to the 70th day, when an active immunization emerged, with a 25 days delay in comparison with controls. Neutralization test in vivo behaved in the same way. The results stress once more the need to give up the use of heterologous immune sera in tetanus prophylaxis, in active-passive immunization as well. Arguments adding force to this point of view are: the sensibilization against heterologous proteins, the very low (if any) passive protective action, and, last not least, the delay in the emergence of active immunization: the only reliable shield against tetanus.

Animals↗

Analysis of serum immune complexes isolated from patients with essential mixed cryoglobulinemia.

The analysis of the molecular composition of serum immune complexes (IC) in autoimmune diseases has assumed growing importance in the evaluation of their clinical significance and possible pathogenetic role. Essential Mixed Cryoglobulinemia (EMC) is typically a disorder characterized by the presence of high levels of IC with pathogenic action, by reduced serum complement levels and by an antiglobulin activity of the cryoprecipitable IgM. In this report we refer on the preliminary results of a study on the molecular composition of the cryoprecipitable IC isolated from the serum of five patients with EMC. The methodology we adopted involves the solubilization at 37 degrees C of the washed cryoprecipitates and the purification of the IgG-containing IC by affinity chromatography through a Protein A-Sepharose CL4B column. The analysis of the molecular component was carried out by electrophoresis in polyacrylamide gel containing sodium-dodecyl-sulphate (SDS-PAGE) followed by Immun-Blot. Our results, although very preliminary, suggest that this kind of study appears really suitable for the detection of specific antibody or antigenic components in the IC molecules involved in the etiopathogenesis of essential mixed cryoglobulinemia.

Antigen-Antibody Complex↗

A new preparation of modified immune serum globulin (human) suitable for intravenous administration. I. Standardization of the reduction and alkylation reaction.

Immune serum globulin (ISG) prepared by Cohn cold alcohol fractionation of pooled human plasma was reduced with dithiothreitol (DTT) and alkylated with iodoacetamide and other alkylating agents. Our results show that there are a few labile interheavy chain disulfide bonds in ISG which react rapidly under mild, nondissociating conditions. The extent of disulfide cleavage is controlled primarily by the ratio of DTT to ISG until about 4-5 disulfide bonds have been reduced. We report detailed studies on the variables of ISG concentration, DTT to ISG ratio, pH, and time, leading to a chemically modified ISG that has a controlled and limited number of reduced and alkylated disulfide bonds.

Disulfides↗